Pfizer Inc.
PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbreā¦ read more
Healthcare
Drug ManufacturersāGeneral
53 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$25.18
Price+0.16%
$0.04
1Y
Price
Market Cap
$143.162b
Large
Price/Earnings 3y Avg5y Avg
13.3x
Premium
Premium
Financials Overview
Key metrics over the past few years+36.3%
EBITDA Margin+19.7%
Net Profit Margin-8.2%
Free Cash Flow MarginRevenue
$63.833b
+0.3%
1y CAGR-11.2%
3y CAGR-2.5%
5y CAGREarnings
$10.728b
+33.8%
1y CAGR+72.2%
3y CAGR+64.6%
5y CAGREPS
$1.88
+33.3%
1y CAGR+73.7%
3y CAGR+65.5%
5y CAGRBook Value
$89.012b
$206.095b
Assets$117.083b
Liabilities$61.797b
DebtDebt to Assets
30.0%
2.7x
Debt to EBITDAFree Cash Flow
$12.438b
+26.5%
1y CAGR+16.7%
3y CAGR+9.3%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company